Efficacy and Safety Study of TJCS for Treatment of Moderate to Severe Dry Eye Syndromes

NCT02461719 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

158

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye Syndromes

Interventions

DRUG: CYPORIN N EYE DROPS 0.05%(TJCS eye drop)
DRUG: Restasis

Sponsor

Taejoon Pharmaceutical Co., Ltd.